<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="20106">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02037711</url>
  </required_header>
  <id_info>
    <org_study_id>SMS2013</org_study_id>
    <nct_id>NCT02037711</nct_id>
  </id_info>
  <brief_title>Intraperitoneal Application of Levobupivacaine During Laparoscopic Surgery in Kids.</brief_title>
  <official_title>Intraperitoneal Instillation of Levobupivacaine in Laparoscopic Pediatric Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <authority>Egypt: Cairo university.</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain after laparoscopic surgery has been associated with surgical manipulations, including
      intraperitoneal insufflation of carbon dioxide (CO2), resulting in peritoneal stretching,
      diaphragmatic irritation, changes in intra-abdominal pH, and retention of the insufflated
      gas in the abdominal cavity after surgery. These effects may result in the irritation of
      peritoneal nerves causing visceral pain, as commonly reported after laparoscopic procedures
      in pediatrics.

      The study hypothesis is that Intraperitoneal local anesthetic (levobupivacaine)
      instillation can provide pain relief after laparoscopic surgery, but local anesthetic
      distribution may not always be uniform throughout the peritoneal surface. Many methods were
      tried for intraperitoneal application of local anesthetics in laparoscopic surgery such as
      local anesthetic (LA) instillation and LA nebulization.

      -But these methods are not widely used in pediatrics upon our knowledge
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver)</study_design>
  <primary_outcome>
    <measure>Postoperative Pain scoring (CHEOPS)</measure>
    <time_frame>up to  six hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>pain score will be assessed immediately postoperative, then after 1 hour, 2 hours, and 6 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in Haemodynamics including ( Heart Rate, Non Invasive Blood Pressure)</measure>
    <time_frame>during the period of the operation (Preoperative, post-induction, after instillation of levobupivacaine or saline, postoperative for 6 hours at 0-1-2-6</time_frame>
    <safety_issue>No</safety_issue>
    <description>Represented as mean and standard deviation, hemodynamic variables will be measured during the the surgery starting preoperatively, following induction of anesthesia, during the procedure and postoperatively (6 hours postoperative)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Indirect signs of local anaesthetic toxicity (intraoperative arrhythmias and delayed awakening)</measure>
    <time_frame>From time of instillation of levobupivacaine till 6 hours postoperative.</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Chirocaine group (levobupivacaine )</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.5%</intervention_name>
    <description>Group I (Chirocaine group) (n=20): Levobupivacaine 0.5% will be instilled during insufflations of CO2 at the beginning of surgery at a dose of 2mg/kg.</description>
    <arm_group_label>Chirocaine group (levobupivacaine )</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Group II (control group) (n=20): laparoscopy done with instillation of normal saline instead of levobupivacain</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient undergoing laparoscopic surgeries

          2. Pediatric weighing 4 kg or more

          3. Patients with free medical history

        Exclusion Criteria:

          1. Parents refusal

          2. Known allergy to levobupivacaine

          3. Acute preoperative pain other than biliary colic

          4. chronic pain treatment or antiepileptic therapy

          5. Severe hepatic or renal impairment

          6. Cognitive impairment or communication problems.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saad El Basha, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maha Gmail, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sherif M Soaida, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>hagar H Refaee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of medicine, Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 15, 2014</lastchanged_date>
  <firstreceived_date>December 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Sherif Mohamed Abd el moneim Soaida, MD</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic</keyword>
  <keyword>Levobupivacaine</keyword>
  <keyword>Pediatric</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Instillation</keyword>
  <keyword>surgeries</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
